Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines ; volume:4 ; number:1 ; day:08 ; month:3 ; year:2004 ; pages:1-8 ; date:12.2004
BMC cancer ; 4, Heft 1 (08.3.2004), 1-8, 12.2004
- Urheber
-
Vishwanatha, Jamboor K.
- Beteiligte Personen und Organisationen
-
Salazar, Eric
Gopalakrishnan, Velliyur K.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-4-8
- URN
-
urn:nbn:de:1111-2016030337268
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vishwanatha, Jamboor K.
- Salazar, Eric
- Gopalakrishnan, Velliyur K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cytokine expression in B-cell non-Hodgkin lymphomas
Non-coding RNA expression profiling of B-cell malignant (non-Hodgkin) lymphomas
Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management
Bioinformatical analysis of B-cell lymphomas
On the cellular immune status of untreated patients with indolent B-cell non-Hodgkin's lymphomas
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Current immunotherapeutic approaches in T cell non-Hodgkin lymphomas
High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas
No association of malignant B‐cell non‐Hodgkin lymphomas with ipsilateral SARS‐CoV‐2 vaccination
Effect of POD24 on the prognosis of follicular and other indolent B-cell non-hodgkin lymphomas
Genomic landscape of mature B-cell non-Hodgkin lymphomas — an appraisal from lymphomagenesis to drug resistance
TOX expression in cutaneous B-cell lymphomas
Cytokine expression in B-cell non-Hodgkin lymphomas
Non-coding RNA expression profiling of B-cell malignant (non-Hodgkin) lymphomas
Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management
Bioinformatical analysis of B-cell lymphomas
On the cellular immune status of untreated patients with indolent B-cell non-Hodgkin's lymphomas
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Current immunotherapeutic approaches in T cell non-Hodgkin lymphomas
High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas
No association of malignant B‐cell non‐Hodgkin lymphomas with ipsilateral SARS‐CoV‐2 vaccination
Effect of POD24 on the prognosis of follicular and other indolent B-cell non-hodgkin lymphomas
Genomic landscape of mature B-cell non-Hodgkin lymphomas — an appraisal from lymphomagenesis to drug resistance
TOX expression in cutaneous B-cell lymphomas
Cytokine expression in B-cell non-Hodgkin lymphomas
Non-coding RNA expression profiling of B-cell malignant (non-Hodgkin) lymphomas
Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management
Bioinformatical analysis of B-cell lymphomas
On the cellular immune status of untreated patients with indolent B-cell non-Hodgkin's lymphomas
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Current immunotherapeutic approaches in T cell non-Hodgkin lymphomas
High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas
No association of malignant B‐cell non‐Hodgkin lymphomas with ipsilateral SARS‐CoV‐2 vaccination
Effect of POD24 on the prognosis of follicular and other indolent B-cell non-hodgkin lymphomas
Genomic landscape of mature B-cell non-Hodgkin lymphomas — an appraisal from lymphomagenesis to drug resistance